Literature DB >> 492346

Difference in behaviour between synthetic and endogenous substance P in human plasma.

D E Cannon, P Skrabanek, D Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 492346     DOI： 10.1007/bf00505941

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  13 in total

1.  Presence of substance P-like immunoreactivity in plasma from man and dog.

Authors:  G Nilsson; B Pernow; G H Fischer; K Folkers
Journal:  Acta Physiol Scand       Date:  1975-08

2.  The catabolism of some physiologically active polypeptides by homogenate of dog hypothalamus.

Authors:  K C HOOPER
Journal:  Biochem J       Date:  1962-06       Impact factor: 3.857

3.  Circulating immunoreactive substance P in man.

Authors:  P Skrabanek; D Cannon; J Kirrane; D Legge; D Powell
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

4.  High-sensitivity radioimmunoassay for substance P.

Authors:  R O'Connell; P Skrabanek; D Cannon; D Powell
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

5.  The stability of synthetic substance P in blood.

Authors:  R W Bury; M L Mashford
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

6.  Comparison of crude bovine subcortical substance P with synthetic substance P.

Authors:  H Iven; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Immunological characterization of two substance-P antisera with substance-P fragments and analogues [proceedings].

Authors:  D Cannon; P Skrabanek; D Powell; M G Harrington
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

8.  Substance P radioimmunoassay using Nalpha-tyrosyl-substance P and demonstration of the presence of substance P-like immunoreactivities in human blood and porcine tissue extracts.

Authors:  C Yanaihara; H Sato; M Hirohashi; M Sakagami; K Yamamoto
Journal:  Endocrinol Jpn       Date:  1976-12

9.  The intestine as source of immunoreactive substance P in plasma of the cat.

Authors:  R Gamse; E Mroz; S Leeman; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

10.  Substance P in rat brain synaptosomes.

Authors:  F Lembeck; N Mayer; G Schindler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000
View more
  1 in total

1.  Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model.

Authors:  Yafeng Song; Per S Stål; Ji-Guo Yu; Ronny Lorentzon; Clas Backman; Sture Forsgren
Journal:  BMC Musculoskelet Disord       Date:  2014-04-11       Impact factor: 2.362
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.